Reproductive and hormonal factors and ovarian cancer
- PMID: 11332145
- DOI: 10.1023/a:1011128408146
Reproductive and hormonal factors and ovarian cancer
Abstract
Background: Menstrual, reproductive and hormonal factors have been related to ovarian cancer risk, but further quantification of their role in various populations is required.
Patients and methods: Cases were 1031 women, below age 79, with incident, histologically confirmed epithelial ovarian cancer, and controls 2411 women, admitted between 1992 and 1999 to a network of hospitals in 4 Italian areas for acute, non-neoplastic, diseases. Odds ratios (OR) were obtained using multiple logistic regression.
Results: Multiparity was associated with a significant reduction in risk of ovarian cancer (OR = 0.6 for 3, and 0.5 for > or = 4 births). No consistent association was observed with time since first or last birth, nor with spontaneous or induced abortions. Late age at menarche (OR = 0.8), and early menopause (OR = 0.6) were inversely related to risk, as did long-term oral contraceptive use (OR = 0.5, for > or = 5 years). Hormone replacement therapy in menopause was associated with a non-significantly elevated risk (OR = 1.4). The pattern of risk was similar for women with and for those without family history of breast or ovarian cancer.
Conclusions: This uniquely large study confirms and further quantities the relation between hormonal and reproductive factors and ovarian cancer. The pattern of risk observed cannot be totally explained by a role of ovulation in ovarian carcinogenesis.
Similar articles
-
Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer.Int J Epidemiol. 2000 Oct;29(5):799-802. doi: 10.1093/ije/29.5.799. Int J Epidemiol. 2000. PMID: 11034959
-
Long-term impact of reproductive factors on cancer risk.Int J Cancer. 1993 Jan 21;53(2):215-9. doi: 10.1002/ijc.2910530207. Int J Cancer. 1993. PMID: 8425757
-
Risk factors for epithelial ovarian tumours of borderline malignancy.Int J Epidemiol. 1991 Dec;20(4):871-7. doi: 10.1093/ije/20.4.871. Int J Epidemiol. 1991. PMID: 1800425
-
Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.Acta Obstet Gynecol Scand. 2004 Sep;83(9):783-95. doi: 10.1111/j.0001-6349.2004.00550.x. Acta Obstet Gynecol Scand. 2004. PMID: 15315588 Review.
-
Epidemiology of ovarian cancer: a summary review.Eur J Cancer Prev. 2001 Apr;10(2):125-9. doi: 10.1097/00008469-200104000-00002. Eur J Cancer Prev. 2001. PMID: 11330452 Review.
Cited by
-
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy.Int J Mol Sci. 2024 Feb 13;25(4):2237. doi: 10.3390/ijms25042237. Int J Mol Sci. 2024. PMID: 38396914 Free PMC article. Review.
-
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer.Cancers (Basel). 2018 Jul 30;10(8):251. doi: 10.3390/cancers10080251. Cancers (Basel). 2018. PMID: 30061485 Free PMC article. Review.
-
Development of a mouse model of menopausal ovarian cancer.Front Oncol. 2014 Feb 26;4:36. doi: 10.3389/fonc.2014.00036. eCollection 2014. Front Oncol. 2014. PMID: 24616881 Free PMC article. Review.
-
Executive Summary of the Ovarian Cancer Evidence Review Conference.Obstet Gynecol. 2023 Jul 1;142(1):179-195. doi: 10.1097/AOG.0000000000005211. Epub 2023 Jun 7. Obstet Gynecol. 2023. PMID: 37348094 Free PMC article.
-
Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.P R Health Sci J. 2010 Sep;29(3):223-31. P R Health Sci J. 2010. PMID: 20799509 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical